Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease
Drugs - Real World Outcomes - Switzerland
doi 10.1007/s40801-019-00171-w
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 2, 2019
Authors
Publisher
Springer Science and Business Media LLC